# Kevin Koch

> Kevin Koch is a Series A investor at OrbiMed (Boulder). See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors)
- Location: Boulder, United States
- Total investments: 3
- Last investment: Apr 2026
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kevinkochphd

Kevin Koch is a Series A investor at OrbiMed in Boulder. Kevin Koch is based out of Boulder, Colorado and is the President and CEO of Edgewise Therapeutics. Kevin previously worked at Biogen as a Senior Vice President, Drug Discovery, Chemical & Molecular Therapeutics. Kevin Koch attended State University of New York, Stony Brook.

## Investment focus

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Terremoto Biosciences | Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $108M | Series C | Apr 15, 2026 |  |
| Terremoto Biosciences | Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $175M | Series B | Nov 02, 2023 |  |
| Terremoto Biosciences | Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $75M | Series A | May 25, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Third Rock Ventures](https://shizune.co/investors/profile/third-rock-ventures) — VC Fund, 6 deals together
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 2 deals together
- [BeOne Medicines Ltd.](https://shizune.co/investors/profile/beone-medicines-ltd) — VC Fund, 1 deal together
- [Cormorant Asset Management](https://shizune.co/investors/profile/cormorant-asset-management) — VC Fund, 1 deal together
- [Cormorant Capital](https://shizune.co/investors/profile/cormorant-capital) — VC Fund, 1 deal together
- [Deep Track Capital](https://shizune.co/investors/profile/deep-track-capital) — VC Fund, 1 deal together

## About OrbiMed

VC Fund · New York, United States

OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investmentsseries of venture capital funds and a family of public equity investment funds.

5 contacts available at OrbiMed.

| Name | Title | Profile |
| --- | --- | --- |
| Dina Chaya | Partner | https://shizune.co/investors/profile/dina-chaya |
| Kevin Koch | Venture Partner | https://shizune.co/investors/profile/kevin-koch |
| Rishi Gupta | Private Equity Partner | https://shizune.co/investors/profile/rishi-gupta |
| Sunny Sharma | Senior Managing Director | https://shizune.co/investors/profile/sunny-sharma |
| Tadd S. Wessel | Managing Director | https://shizune.co/investors/profile/tadd-s-wessel |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### When did Kevin Koch last invest?

The most recent investment recorded for Kevin Koch closed in Apr 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co